secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2026-06-05T20:30:44+00:00
Accession:  0001493152-26-027499
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics announces resignation of two directors and COO; COO to serve as consultant
--------------------------------------------------------------------------------

- David E. Lazar and Avraham Ben-Tzvi resigned from all director positions and committees effective June 5, 2026.
- Walt A. Linscott resigned as COO effective June 1, 2026, and will serve as consultant under a consulting agreement.
- Resignations were not due to any disagreement with the company's operations, policies, or practices.
- No replacements for directors or COO were announced; CEO Junyi Dai remains in place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer